We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
989

Sector Composition

Rank Sector Weight
1 Technology 6.08%
2 Financials 6.03%
3 Industrials 5.01%
4 Consumer Discretionary 4.73%
5 Healthcare 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PGH
8676
PUT
DELISTED
Pengrowth Energy Corporation
PGH
-31,400
Closed -$32K
ESV
8677
DELISTED
Ensco Rowan plc
ESV
-1,414,238
Closed -$31.3M
IIP
8678
CALL
DELISTED
INTERNAP NETWORK SERVICES CORPORATION
IIP
-19,600
Closed -$85K
IIP
8679
DELISTED
INTERNAP NETWORK SERVICES CORPORATION
IIP
-40,606
Closed -$177K
PDLI
8680
CALL
DELISTED
PDL BioPharma, Inc.
PDLI
-23,300
Closed -$79K
PDLI
8681
DELISTED
PDL BioPharma, Inc.
PDLI
-219,860
Closed -$745K
VIA
8682
CALL
DELISTED
Viacom Inc. Class A
VIA
-6,100
Closed -$224K
BSCH
8683
DELISTED
Guggenheim BulletShares 2017 Corporate Bond ETF
BSCH
-29,531
Closed -$668K
LUNA
8684
DELISTED
Luna Innovations Incorporated
LUNA
-13,761
Closed -$23K
VSTO
8685
DELISTED
Vista Outdoor Inc.
VSTO
-572,984
Closed -$10M
VSTO
8686
PUT
DELISTED
Vista Outdoor Inc.
VSTO
-61,400
Closed -$1.41M
DXGE
8687
DELISTED
WisdomTree Germany Hedged Equity Fund
DXGE
-24,263
Closed -$764K
YELL
8688
DELISTED
Yellow Corporation Common Stock
YELL
-175,496
Closed -$2.31M
HSKA
8689
DELISTED
Heska Corp
HSKA
-14,199
Closed -$1.25M
REV
8690
DELISTED
Revlon, Inc.
REV
-125,830
Closed -$2.79M
REGI
8691
CALL
DELISTED
Renewable Energy Group, Inc.
REGI
-11,600
Closed -$141K
PSXP
8692
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
-13,922
Closed -$693K
MBT
8693
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
-38,930
Closed -$402K
UFS
8694
DELISTED
DOMTAR CORPORATION (New)
UFS
-130,789
Closed -$6.08M
CBB
8695
DELISTED
Cincinnati Bell Inc.
CBB
-62,237
Closed -$1.24M
CKH
8696
PUT
DELISTED
Seacor Holdings Inc.
CKH
-206,800
Closed -$9.22M
TAT
8697
DELISTED
TransAtlantic Petroleum LTD.
TAT
-22,439
Closed -$19K
KGJI
8698
DELISTED
Kingold Jewelry Inc.
KGJI
-2,332
Closed -$29K
AUO
8699
DELISTED
AU Optronics Corp
AUO
-10,565
Closed -$43K
TRCO
8700
PUT
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
-8,100
Closed -$331K

Similar funds

Citadel Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Citadel Advisors held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Citadel Advisors deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Citadel Advisors's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Citadel Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Citadel Advisors's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Citadel Advisors opened 1,440 new positions and closed 989 in Q4 2017.
  • Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.